![]() Revance Therapeutics Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings. | ![]() Evofem Biosciences Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products. | ![]() Hallura Hallura is an aesthetic medical company developing a new generation of hyaluronic acid (HA) dermal fillers. | ||
Founding Date | Founding Date 2002 | Founding Date 2007 | Founding Date 2017 | Founding Date 1975 |
Type | Type Public | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Nashville, US HQ Irvine, US Newark, US Pleasanton, US | Locations San Diego, US HQ | Locations Yokne'am Illit, IL HQ | Locations Farmville, US HQ |
Employees | Employees 59712% increase | Employees 3030% increase | Employees 215% increase | Employees 40 |
Valuation ($) | Valuation ($) 615.7 m | Valuation ($) 1.2 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $234m (FY, 2023) | Revenue (est.) $20.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $74.4m (FY, 2023) | Cost of goods $4.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $159.7m (FY, 2023) | Gross profit $15.6m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($324m) (FY, 2023) | Net income $391k (FY, 2025) | Net income N/A | Net income N/A |

Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products.
View company
Hallura is an aesthetic medical company developing a new generation of hyaluronic acid (HA) dermal fillers.
View company